Skip to Content



Definition: An oral multitargeted tyrosine kinase inhibitor with particular activity against BCR-ABL; used in the treatment of chronic myeloid leukemia, especially in cases with the T315I mutation.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

© Copyright 2018 Wolters Kluwer. All Rights Reserved. Review date: Sep 19, 2016.